Omnicell reported strong financial results for the first quarter of 2025, with total revenues of $270 million, up 10% year-over-year, and non-GAAP net income of $12 million, or $0.26 per diluted share. This exceeded the company's guidance ranges for both metrics. The increase in revenue was primarily driven by the XT Amplify program and growth in SaaS and Expert Services.
Total revenues for Q1 2025 were $270 million, a 10% increase compared to Q1 2024.
GAAP net loss for Q1 2025 was $7 million, or $0.15 per diluted share, an improvement from a $16 million loss in Q1 2024.
Non-GAAP net income for Q1 2025 was $12 million, or $0.26 per diluted share, significantly higher than $1 million in Q1 2024.
Cash and cash equivalents stood at $387 million as of March 31, 2025.
Omnicell provided guidance for the second quarter and updated its full-year 2025 guidance, reducing the ranges for non-GAAP EBITDA and non-GAAP EPS due to potential higher supply chain costs related to tariffs.
Analyze how earnings announcements historically affect stock price performance